▶ 調査レポート

世界の尿路上皮がんの治療市場:市場規模・現状・予測

• 英文タイトル:Global Urothelial Carcinoma Treatment Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界の尿路上皮がんの治療市場:市場規模・現状・予測 / Global Urothelial Carcinoma Treatment Market Size, Status and Forecast 2019-2025 / QYR9N8160資料のイメージです。• レポートコード:QYR9N8160
• 出版社/出版日:QYResearch / 2019年6月14日
• レポート形態:英文、PDF、99ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥421,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥842,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当資料は、尿路上皮がんの治療のグローバル市場について調査・分析したレポートで、種類別(免疫療法、放射線療法、化学療法)、用途別(病院、診療所、その他)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・尿路上皮がんの治療の世界市場規模
・主要企業別市場シェア
・尿路上皮がんの治療の世界市場規模:種類別(免疫療法、放射線療法、化学療法)
・尿路上皮がんの治療の世界市場規模:用途別(病院、診療所、その他)
・尿路上皮がんの治療のアメリカ市場規模(種類別、用途別)
・尿路上皮がんの治療のヨーロッパ市場規模(種類別、用途別)
・尿路上皮がんの治療の中国市場規模(種類別、用途別)
・尿路上皮がんの治療の日本市場規模(種類別、用途別)
・尿路上皮がんの治療の東南アジア市場規模(種類別、用途別)
・尿路上皮がんの治療のインド市場規模(種類別、用途別)
・尿路上皮がんの治療の中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・尿路上皮がんの治療の世界市場予測(2019年-2025年)
・尿路上皮がんの治療の地域別市場予測(2019年-2025年)
...

Urothelial carcinoma is also called as transitional cell carcinoma which is a cancerous tumor of the bladder that can spread to other parts of the body. These are also called as malignant tumors. This tumor can start at any part of the urinary tract. People with bladder cancer may also have similar cancer in other parts of the urinary tract.Americas is likely to dominate the urothelial carcinoma treatment market owing to the increasing prevalence of bladder cancer, increasing investment in research and development of new bladder cancer treatment.
In 2018, the global Urothelial Carcinoma Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Urothelial Carcinoma Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Urothelial Carcinoma Treatment development in United States, Europe and China.

The key players covered in this study
GlaxoSmithKline
Novartis
Merck
Sanofi
Bristol-Myers Squibb
Genentech
Eisai
Dendreon

Market segment by Type, the product can be split into
Immunotherapy
Radiotherapy
Chemotherapy

Market segment by Application, split into
Hospitals
Clinics
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Urothelial Carcinoma Treatment status, future forecast, growth opportunity, key market and key players.
To present the Urothelial Carcinoma Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Urothelial Carcinoma Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Urothelial Carcinoma Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Immunotherapy
1.4.3 Radiotherapy
1.4.4 Chemotherapy
1.5 Market by Application
1.5.1 Global Urothelial Carcinoma Treatment Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Urothelial Carcinoma Treatment Market Size
2.2 Urothelial Carcinoma Treatment Growth Trends by Regions
2.2.1 Urothelial Carcinoma Treatment Market Size by Regions (2014-2025)
2.2.2 Urothelial Carcinoma Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Urothelial Carcinoma Treatment Market Size by Manufacturers
3.1.1 Global Urothelial Carcinoma Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Urothelial Carcinoma Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Urothelial Carcinoma Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Urothelial Carcinoma Treatment Key Players Head office and Area Served
3.3 Key Players Urothelial Carcinoma Treatment Product/Solution/Service
3.4 Date of Enter into Urothelial Carcinoma Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Urothelial Carcinoma Treatment Market Size by Type (2014-2019)
4.2 Global Urothelial Carcinoma Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Urothelial Carcinoma Treatment Market Size (2014-2019)
5.2 Urothelial Carcinoma Treatment Key Players in United States
5.3 United States Urothelial Carcinoma Treatment Market Size by Type
5.4 United States Urothelial Carcinoma Treatment Market Size by Application

6 Europe
6.1 Europe Urothelial Carcinoma Treatment Market Size (2014-2019)
6.2 Urothelial Carcinoma Treatment Key Players in Europe
6.3 Europe Urothelial Carcinoma Treatment Market Size by Type
6.4 Europe Urothelial Carcinoma Treatment Market Size by Application

7 China
7.1 China Urothelial Carcinoma Treatment Market Size (2014-2019)
7.2 Urothelial Carcinoma Treatment Key Players in China
7.3 China Urothelial Carcinoma Treatment Market Size by Type
7.4 China Urothelial Carcinoma Treatment Market Size by Application

8 Japan
8.1 Japan Urothelial Carcinoma Treatment Market Size (2014-2019)
8.2 Urothelial Carcinoma Treatment Key Players in Japan
8.3 Japan Urothelial Carcinoma Treatment Market Size by Type
8.4 Japan Urothelial Carcinoma Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Urothelial Carcinoma Treatment Market Size (2014-2019)
9.2 Urothelial Carcinoma Treatment Key Players in Southeast Asia
9.3 Southeast Asia Urothelial Carcinoma Treatment Market Size by Type
9.4 Southeast Asia Urothelial Carcinoma Treatment Market Size by Application

10 India
10.1 India Urothelial Carcinoma Treatment Market Size (2014-2019)
10.2 Urothelial Carcinoma Treatment Key Players in India
10.3 India Urothelial Carcinoma Treatment Market Size by Type
10.4 India Urothelial Carcinoma Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Urothelial Carcinoma Treatment Market Size (2014-2019)
11.2 Urothelial Carcinoma Treatment Key Players in Central & South America
11.3 Central & South America Urothelial Carcinoma Treatment Market Size by Type
11.4 Central & South America Urothelial Carcinoma Treatment Market Size by Application

12 International Players Profiles
12.1 GlaxoSmithKline
12.1.1 GlaxoSmithKline Company Details
12.1.2 Company Description and Business Overview
12.1.3 Urothelial Carcinoma Treatment Introduction
12.1.4 GlaxoSmithKline Revenue in Urothelial Carcinoma Treatment Business (2014-2019)
12.1.5 GlaxoSmithKline Recent Development
12.2 Novartis
12.2.1 Novartis Company Details
12.2.2 Company Description and Business Overview
12.2.3 Urothelial Carcinoma Treatment Introduction
12.2.4 Novartis Revenue in Urothelial Carcinoma Treatment Business (2014-2019)
12.2.5 Novartis Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Urothelial Carcinoma Treatment Introduction
12.3.4 Merck Revenue in Urothelial Carcinoma Treatment Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Urothelial Carcinoma Treatment Introduction
12.4.4 Sanofi Revenue in Urothelial Carcinoma Treatment Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 Bristol-Myers Squibb
12.5.1 Bristol-Myers Squibb Company Details
12.5.2 Company Description and Business Overview
12.5.3 Urothelial Carcinoma Treatment Introduction
12.5.4 Bristol-Myers Squibb Revenue in Urothelial Carcinoma Treatment Business (2014-2019)
12.5.5 Bristol-Myers Squibb Recent Development
12.6 Genentech
12.6.1 Genentech Company Details
12.6.2 Company Description and Business Overview
12.6.3 Urothelial Carcinoma Treatment Introduction
12.6.4 Genentech Revenue in Urothelial Carcinoma Treatment Business (2014-2019)
12.6.5 Genentech Recent Development
12.7 Eisai
12.7.1 Eisai Company Details
12.7.2 Company Description and Business Overview
12.7.3 Urothelial Carcinoma Treatment Introduction
12.7.4 Eisai Revenue in Urothelial Carcinoma Treatment Business (2014-2019)
12.7.5 Eisai Recent Development
12.8 Dendreon
12.8.1 Dendreon Company Details
12.8.2 Company Description and Business Overview
12.8.3 Urothelial Carcinoma Treatment Introduction
12.8.4 Dendreon Revenue in Urothelial Carcinoma Treatment Business (2014-2019)
12.8.5 Dendreon Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Urothelial Carcinoma Treatment Key Market Segments
Table Key Players Urothelial Carcinoma Treatment Covered
Table Global Urothelial Carcinoma Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Urothelial Carcinoma Treatment Market Size Market Share by Type 2014-2025
Figure Immunotherapy Figures
Table Key Players of Immunotherapy
Figure Radiotherapy Figures
Table Key Players of Radiotherapy
Figure Chemotherapy Figures
Table Key Players of Chemotherapy
Table Global Urothelial Carcinoma Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Clinics Case Studies
Figure Others Case Studies
Figure Urothelial Carcinoma Treatment Report Years Considered
Table Global Urothelial Carcinoma Treatment Market Size 2014-2025 (Million US$)
Figure Global Urothelial Carcinoma Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Urothelial Carcinoma Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Urothelial Carcinoma Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Urothelial Carcinoma Treatment Market Share by Regions 2014-2019
Figure Global Urothelial Carcinoma Treatment Market Share by Regions 2014-2019
Figure Global Urothelial Carcinoma Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Urothelial Carcinoma Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Urothelial Carcinoma Treatment Market Share by Manufacturers (2014-2019)
Figure Global Urothelial Carcinoma Treatment Market Share by Manufacturers in 2018
Table Global Urothelial Carcinoma Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Urothelial Carcinoma Treatment Product/Solution/Service
Table Date of Enter into Urothelial Carcinoma Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Urothelial Carcinoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Urothelial Carcinoma Treatment Market Size Share by Type (2014-2019)
Figure Global Urothelial Carcinoma Treatment Market Size Market Share by Type (2014-2019)
Table Global Urothelial Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Urothelial Carcinoma Treatment Market Size Share by Application (2014-2019)
Figure Global Urothelial Carcinoma Treatment Market Size Market Share by Application (2014-2019)
Figure Global Urothelial Carcinoma Treatment Revenue Market Share by Application in 2018
Figure United States Urothelial Carcinoma Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Urothelial Carcinoma Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Urothelial Carcinoma Treatment Market Share (2018-2019)
Table United States Urothelial Carcinoma Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Urothelial Carcinoma Treatment Market Share by Type (2014-2019)
Table United States Urothelial Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Urothelial Carcinoma Treatment Market Share by Application (2014-2019)
Figure Europe Urothelial Carcinoma Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Urothelial Carcinoma Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Urothelial Carcinoma Treatment Market Share (2018-2019)
Table Europe Urothelial Carcinoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Urothelial Carcinoma Treatment Market Share by Type (2014-2019)
Table Europe Urothelial Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Urothelial Carcinoma Treatment Market Share by Application (2014-2019)
Figure China Urothelial Carcinoma Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Urothelial Carcinoma Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Urothelial Carcinoma Treatment Market Share (2018-2019)
Table China Urothelial Carcinoma Treatment Market Size by Type (2014-20189) (Million US$)
Table China Urothelial Carcinoma Treatment Market Share by Type (2014-2019)
Table China Urothelial Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table China Urothelial Carcinoma Treatment Market Share by Application (2014-2019)
Figure Japan Urothelial Carcinoma Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Urothelial Carcinoma Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Urothelial Carcinoma Treatment Market Share (2018-2019)
Table Japan Urothelial Carcinoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Urothelial Carcinoma Treatment Market Share by Type (2014-2019)
Table Japan Urothelial Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Urothelial Carcinoma Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Urothelial Carcinoma Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Urothelial Carcinoma Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Urothelial Carcinoma Treatment Market Share (2018-2019)
Table Southeast Asia Urothelial Carcinoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Urothelial Carcinoma Treatment Market Share by Type (2014-2019)
Table Southeast Asia Urothelial Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Urothelial Carcinoma Treatment Market Share by Application (2014-2019)
Figure India Urothelial Carcinoma Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Urothelial Carcinoma Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Urothelial Carcinoma Treatment Market Share (2018-2019)
Table India Urothelial Carcinoma Treatment Market Size by Type (2014-2019) (Million US$)
Table India Urothelial Carcinoma Treatment Market Share by Type (2014-2019)
Table India Urothelial Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table India Urothelial Carcinoma Treatment Market Share by Application (2014-2019)
Figure Central & South America Urothelial Carcinoma Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Urothelial Carcinoma Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Urothelial Carcinoma Treatment Market Share (2018-2019)
Table Central & South America Urothelial Carcinoma Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Urothelial Carcinoma Treatment Market Share by Type (2014-2019)
Table Central & South America Urothelial Carcinoma Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Urothelial Carcinoma Treatment Market Share by Application (2014-2019)
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Urothelial Carcinoma Treatment Business (2014-2019) (Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Novartis Company Details
Table Novartis Revenue in Urothelial Carcinoma Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Revenue in Urothelial Carcinoma Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2014-2019)
Table Merck Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Urothelial Carcinoma Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2014-2019)
Table Sanofi Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Revenue in Urothelial Carcinoma Treatment Business (2014-2019)(Million US$)
Figure Bristol-Myers Squibb Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Genentech Company Details
Table Genentech Revenue in Urothelial Carcinoma Treatment Business (2014-2019)(Million US$)
Figure Genentech Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2014-2019)
Table Genentech Recent Development
Table Eisai Company Details
Table Eisai Revenue in Urothelial Carcinoma Treatment Business (2014-2019)(Million US$)
Figure Eisai Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2014-2019)
Table Eisai Recent Development
Table Dendreon Company Details
Table Dendreon Revenue in Urothelial Carcinoma Treatment Business (2014-2019)(Million US$)
Figure Dendreon Revenue Growth Rate in Urothelial Carcinoma Treatment Business (2014-2019)
Table Dendreon Recent Development
Table Global Urothelial Carcinoma Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Urothelial Carcinoma Treatment Market Size Share by Regions (2019-2025)
Figure Global Urothelial Carcinoma Treatment Market Size Share by Regions in 2025
Figure United States Urothelial Carcinoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Urothelial Carcinoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Urothelial Carcinoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Urothelial Carcinoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Urothelial Carcinoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Urothelial Carcinoma Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Urothelial Carcinoma Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Urothelial Carcinoma Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Urothelial Carcinoma Treatment Market Size by Product (2019-2025)
Figure Global Urothelial Carcinoma Treatment Market Size by Product in 2025
Table Global Urothelial Carcinoma Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Urothelial Carcinoma Treatment Market Size by Application (2019-2025)
Figure Global Urothelial Carcinoma Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources